Scilex Holding (SCLXW) Research & Development (2022 - 2026)

Scilex Holding (SCLXW) recorded quarterly Research & Development of $3.2 million in Q1 2026, down 60.7% quarter-over-quarter from $8.2 million in Q4 2025, and up 30.7% on a YoY basis from $2.5 million in Q1 2025.

Scilex Holding (SCLXW) Research & Development (2022 - 2026) Analysis & Trends

Scilex Holding's Research & Development history runs 5 years deep, the most recent figure standing at $3.2 million for Q1 2026.

  • In Q1 2026, Research & Development rose 30.7% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $21.5 million (up 138.78% YoY), while the FY2025 annual figure was $20.7 million, up 114.81% from the prior year.
  • Research & Development was $3.2 million for Q1 2026 at Scilex Holding, down from $8.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $8.2 million in Q4 2025 to a low of $1.2 million in Q3 2022.
  • Historically, Research & Development has averaged $3.3 million across 5 years, with a median of $2.7 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Research & Development tumbled 42.31% in 2024, then jumped 274.68% in 2025.
  • A 5-year view of Research & Development shows it stood at $2.6 million in 2022, then grew by 5.28% to $2.7 million in 2023, then dropped by 20.26% to $2.2 million in 2024, then surged by 274.68% to $8.2 million in 2025, then sank by 60.7% to $3.2 million in 2026.
  • The last three Research & Development figures came in at $3.2 million (Q1 2026), $8.2 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -2.28 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 3.51 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 3.53 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 2.47 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 12.59 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.72 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.37 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 2.49 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 2.65 Bn
10 Scilex Holding - - 4.15 Mn 3.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.21 Mn
Dec 31, 2025 8.17 Mn
Sep 30, 2025 3.90 Mn
Jun 30, 2025 6.19 Mn
Mar 31, 2025 2.46 Mn
Dec 31, 2024 2.18 Mn
Sep 30, 2024 2.35 Mn
Jun 30, 2024 2.00 Mn
Mar 31, 2024 3.11 Mn
Dec 31, 2023 2.73 Mn
Sep 30, 2023 4.07 Mn
Jun 30, 2023 3.20 Mn
Mar 31, 2023 2.74 Mn
Dec 31, 2022 2.60 Mn
Sep 30, 2022 1.24 Mn
Jun 30, 2022 2.59 Mn
Mar 31, 2022 2.63 Mn